The Patient-Reported Outcomes in Actinic Keratosis (PROAK) study investigated the effectiveness and ...

Helping you achieve your professional and personal aspirations!
IMPORTANT NOTICES: Any medical information on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a licensed healthcare professional.
Any licensed healthcare professional in a healthcare encounter must independently make decisions on medical testing, diagnosis, medication prescribing, and treatment administration based upon their professional judgement and training regardless of the information on this website.
The Patient-Reported Outcomes in Actinic Keratosis (PROAK) study investigated the effectiveness and ...
In this video blog, Susan Taylor, MD, discusses highlights from her lecture Central Centrifugal Cica...
The FDA has accepted Arcutis Biotherapeutics' Supplemental New Drug Application for ZORYVE® (roflumi...
Update on Alopecia Areata (Jerry Shapiro, MD)
Published online November 7, 2023, the American Academy of Dermatology (AAD) provided an update to t...
The month of August was psoriasis awareness month and I wanted to shed some light (not phototherapy)...
Updates in Immunobullous Disorders (Brittney Schultz, MD)
I recently had a male-to-female transitioning (MTF) patient present with a 2cm painless, protruding,...
Central Centrifugal Cicatricial Alopecia (Susan Taylor, MD)
It’s finally summer–and time to get outside and enjoy the nice weather! Maybe it’s a beach vacation,...